Chongqing Pharscin Pharmaceutical Co Ltd (002907) — Cash Flow-to-Debt Ratio
Chongqing Pharscin Pharmaceutical Co Ltd (002907) has a Cash Flow-to-Debt Ratio of 0.00x as of September 2025, meaning its operating cash flow of CN¥833.94K could theoretically repay 0% of its total liabilities (CN¥287.66 Million) in one year. Check 002907 cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Chongqing Pharscin Pharmaceutical Co Ltd Cash Flow-to-Debt Ratio (2013–2024)
Historical debt coverage capacity for Chongqing Pharscin Pharmaceutical Co Ltd across 12 annual periods. Also explore 002907 current and non-current assets for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Chongqing Pharscin Pharmaceutical Co Ltd (2013–2024)
Year-by-year debt coverage analysis for Chongqing Pharscin Pharmaceutical Co Ltd. For market capitalisation and broader financial context, see Chongqing Pharscin Pharmaceutical Co Ltd stock valuation.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | 0.63x | CN¥161.77 Million | CN¥257.55 Million | ▼ -33.1% |
| 2023 | 0.94x | CN¥219.34 Million | CN¥233.53 Million | ▲ +1745.2% |
| 2022 | 0.05x | CN¥13.04 Million | CN¥256.28 Million | ▼ -68.9% |
| 2021 | 0.16x | CN¥82.85 Million | CN¥505.56 Million | ▼ -22.2% |
| 2020 | 0.21x | CN¥113.64 Million | CN¥539.59 Million | ▲ +81.0% |
| 2019 | 0.12x | CN¥65.92 Million | CN¥566.67 Million | ▼ -3.2% |
| 2018 | 0.12x | CN¥31.80 Million | CN¥264.72 Million | ▼ -75.6% |
| 2017 | 0.49x | CN¥81.34 Million | CN¥165.20 Million | ▲ +62.8% |
| 2016 | 0.30x | CN¥57.73 Million | CN¥190.91 Million | ▼ -20.6% |
| 2015 | 0.38x | CN¥66.10 Million | CN¥173.59 Million | ▲ +347.5% |
| 2014 | 0.09x | CN¥20.22 Million | CN¥237.62 Million | ▼ -68.7% |
| 2013 | 0.27x | CN¥47.34 Million | CN¥174.39 Million | — |